AR041090A1 - Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral - Google Patents

Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral

Info

Publication number
AR041090A1
AR041090A1 ARP030103129A ARP030103129A AR041090A1 AR 041090 A1 AR041090 A1 AR 041090A1 AR P030103129 A ARP030103129 A AR P030103129A AR P030103129 A ARP030103129 A AR P030103129A AR 041090 A1 AR041090 A1 AR 041090A1
Authority
AR
Argentina
Prior art keywords
birds
heat
assistant
corral
toxin
Prior art date
Application number
ARP030103129A
Other languages
English (en)
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of AR041090A1 publication Critical patent/AR041090A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se refiere a composiciones y métodos para utilizar la toxina lábil al calor de E. coli (TL) y sus análogos como adyuvantes en aves. Además describe composiciones y métodos pata utilizar TL producida por plantas, sus análogos conocidos y los inmunógenos protectores como vacunas en aves.
ARP030103129A 2002-08-27 2003-08-28 Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral AR041090A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40635902P 2002-08-27 2002-08-27

Publications (1)

Publication Number Publication Date
AR041090A1 true AR041090A1 (es) 2005-05-04

Family

ID=31978291

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103129A AR041090A1 (es) 2002-08-27 2003-08-28 Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral

Country Status (12)

Country Link
US (1) US20040146533A1 (es)
EP (1) EP1551451B1 (es)
JP (1) JP2005539039A (es)
CN (1) CN100435844C (es)
AR (1) AR041090A1 (es)
AT (1) ATE423569T1 (es)
AU (1) AU2003274925A1 (es)
BR (1) BR0314088A (es)
CA (1) CA2491568A1 (es)
DE (1) DE60326369D1 (es)
ES (1) ES2320119T3 (es)
WO (1) WO2004020585A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100387719C (zh) * 2005-05-09 2008-05-14 中国农业科学院生物技术研究所 编码大肠杆菌热敏毒素基因及其表达载体和用途
JP5014413B2 (ja) 2006-03-30 2012-08-29 エンブレックス・インコーポレイテッド 家禽のワクチン接種のための方法及び組成物
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
WO2010021289A1 (ja) * 2008-08-18 2010-02-25 学校法人北里研究所 トリインフルエンザウイルス抗原及び経口投与で有効な粘膜アジュバントを併用したトリインフルエンザワクチンの追加免疫方法
KR20120101572A (ko) * 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
NZ297142A (en) * 1994-10-24 2001-09-28 Texas A & M Univ Sys Oral immunisation and oral vaccines using edible transgenic plants comprising immunogenic agents such as E coli and cholera toxin antigens
US6395964B1 (en) * 1995-10-24 2002-05-28 The Texas A&M University System Oral immunization with transgenic plants
JP2002533068A (ja) * 1998-12-22 2002-10-08 ボイス トンプソン インスティテュート フォア プラント リサーチ トランスジェニック植物に発現される経口で免疫原性の細菌エンテロトキシン

Also Published As

Publication number Publication date
WO2004020585A3 (en) 2004-08-12
ES2320119T3 (es) 2009-05-19
AU2003274925A1 (en) 2004-03-19
CN100435844C (zh) 2008-11-26
EP1551451A2 (en) 2005-07-13
AU2003274925A8 (en) 2004-03-19
DE60326369D1 (de) 2009-04-09
BR0314088A (pt) 2005-07-19
US20040146533A1 (en) 2004-07-29
WO2004020585B1 (en) 2004-10-07
EP1551451A4 (en) 2005-11-16
JP2005539039A (ja) 2005-12-22
WO2004020585A2 (en) 2004-03-11
CN1678343A (zh) 2005-10-05
EP1551451B1 (en) 2009-02-25
ATE423569T1 (de) 2009-03-15
CA2491568A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
PA8617701A1 (es) Nuevos compuestos farmaceuticos
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
CR9781A (es) 1h-imidazopiridinas sustituidas con hidroxi y procedimientos
CR8254A (es) [1,8] naftidrin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
PA8609201A1 (es) Piridinonas sustituidas
PA8577001A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
GT200600518A (es) Derivados de pirimidina
UY28680A1 (es) Fenilalanina-amidas sustituidas por heteroaroilo .
GT200600519A (es) Herbicidas novedosos
ECSP055801A (es) Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas
AR054251A1 (es) Vacuna de toxoide de c. perfringens alfa
UY30481A1 (es) Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
BRPI0513144A (pt) certos compostos de fosfato de glucosaminida de aminoalquila e seu uso
AR028948A1 (es) Compuestos novedosos
PA8577101A1 (es) Nuevos derivados de glicosido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
PA8576101A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
DOP2006000017A (es) Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso
ECSP088963A (es) Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmacéuticas que las comprenden
CR8092A (es) Pirazolopirimidinas sustituidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos, asi como productos que las contienen
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
GT200400033A (es) Compuestos arilvinilazacicloalcano y metodos de preparacion y uso de ellos

Legal Events

Date Code Title Description
FB Suspension of granting procedure